• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Imatinib
    3 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Glivec
    Novartis
    RX
    partial basket chart
    Glivec

    Tyrosine Kinase Inhibitor. Imatinib 100 mg, 400 mg.
    F.C. TABS: 20, 60 x 100 mg; 10, 30 x
    400mg.
    Doses of 400 mg or 600 mg should be
    admin. once dly., whereas a daily dose
    of 800 mg should be admin. as 400 mg
    ×2/d in the morn. and even.
    Tmt. of adult pts. and child. 3 yrs. of age
    and above with Ph+ chron. myeloid
    leukaemia (Ph+ -CML) in chron. phase
    accelerat. phase or blast crisis. Glivec is
    also indicat. for the tmt. of adult pts.s
    with Kit (CD117) posit. unresect. and/or
    metastat. malignant GI strom. tumour.
    (GIST). Also indicated for the tmt. of :
    Adult pts. with newly diagnosed
    Philadelphia chromos. posit. acute
    lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. Adult pts.
    with relapsed or refract. Ph + ALL as
    monother. Adult pts. with unresect.
    dermatofibrosarcoma protuberans
    (DFSP) and adult pts. with recurrent and/
    or metastat. DFSP who are not eligible
    for surg. Adult pts. with myelodyspiastic/
    myeloproliferative dis.(MDS/MPD) assoc.
    with PDGFR ( platelet - derived growth
    factor recept. ) gene re- arrangements.
    Adult pts. with hypereosinophilic syndr.
    (HES) and/or chronic eosinophilic
    leukaemia (CEL) who have the FIP1L1-
    PDGFRalfa fusion kinase (mutational
    analysis or FISH demonstration fo CHIC2
    allele deletion) and for pts. with HES and/
    or CEL who are FIP1L1-PDGFR alfa fusion
    kinase negative . Adult pts. with aggress.
    systemic mastocytosis (ASM) without the
    D816V c-kit mutation .Adjuvant tmt. of
    adult pts. follow. complete gross resec. of
    Kit (CD117) positive GIST.
    C/I: Hypersens.

    Imatinib Taro
    Taro International Ltd
    RX
    full basket chart
    Imatinib Taro

    Protein Kinase Inhibitor. Imatinib 100 mg, 400 mg.
    FC Tabs. 60X100 mg, 30X400 mg. Ther. should be init. by a phys. exper. in tmt. of  hematological malign. and malign. sarcomas. See lit.

    Tmt of adlt. pts. and child. 3 years of age and above with Ph+ chron. myeloid leukaemia (Ph+ -CML) in chron. phase, accel phase or blast crisis.• Tmt of adlt. pts. with Kit (CD117) posit. unresect. and/or metast. malign. GI stromal tumours (GIST). • Adjuv. tmt of adlt. pts. follow. compl. gross resect. of Kit (CD117) posit. GIST.• Tmt of adlt. pts. with newly diagn. Philadelphia chrom. posit. ac. lymphoblastic leukemia (Ph+ ALL) integr. with chemother. • Tmt. of adlt. pts. with relapsed or refract. Ph+ ALL as monother. • Tmt. of adlt. pts. with unresect. dermatofibrosarcoma protuberans (DFSP) and adlt. pts. with recur. and/or metast. DFSP who are not elig. for surgery.• Tmt. of adlt. pts. with myelodysplastic/myeloproliferat. dis. (MDS/MPD) assoc. with PDGFR (platelet-derived growth factor receptor) gene re-arrangements. • Tmt. of adlt. pts. with hypereosinophilic syndr. (HES) and/or chron. eosinophilic leukaemia (CEL) who have the FIP1L1-PDGFRα fusion kinase (mutation. analysis or FISH demonstr. of CHIC2 allele delet.) and for pts. with HES and/or CEL who are FIP1L1- PDGFRα fusion kinase neg. • Tmt. of adlt. pt.s with aggress. syst. mastocytosis (ASM) without the D816V c-kit mutat.
    C/I: Hypersens.

    Imatinib Teva
    Teva
    RX
    partial basket chart
    Imatinib Teva

    Protein Kinase Inhibitor. Imatinib 100 mg, 400 mg.
    TABS:60X100 mg, 30X400 mg. -
    400 mg or 600 ×1/d, whereas a dly.-
    dose of 800 mg should be administ. as-
    400 mg ×2/d , in the morn. and in the-
    even. Tmt. should be cont. as long-
    as the pt. cont. to benefit. Should be-
    administ. P.O. with meal and a large-
    glass of water. See lit.-
    Tmt. of adult pts. and child. ≥ 3yrs. with-
    Ph+ -CML in chron. phase acceler. phase-
    or blast crisis. Tmt. of adult pts. with newly-
    diagnosed Philadelphia chromosome-
    posit. Ph+ ALL integrated with chemother..-
    Adult pts. with relapsed or refractory Ph +-
    ALL as monother. Adult pts. with unresec.-
    DFSP and adult pts. with recur. and/or-
    metast. DFSP who are not eligible for-
    surgery. Adult pts. with MDS/MPD assoc.-
    with PDGFR gene re- arrang. Adult pts.-
    with HES and/or CEL who have the FIP1L1--
    PDGFR alfa fusion kinase (mutational-
    analysis or FISH demonst. for CHIC2 allele-
    deletion) and for pts. with HES and/or CEL-
    who are FIP1L1-PDGFR alfa fusion kinase-
    negative . Adult pts. with ASM without the-
    D816V c-kit mutation. Adult pts. with Kit (CD117) -
    posit. unresect. and/or metast. malignant GIST. -
    Adjuv. tmt. of adult pts. following compl.-
    gross resect. of Kit (CD117) posit. GIST.-
    C/I: Hypersens.

    CLOSE